Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and -independent mechanisms
Aura D. Herrera‐Martínez(Instituto Maimónides de Investigación Biomédica de Córdoba), Raúl M. Luque(Instituto de Salud Carlos III), Mari C. Vázquez‐Borrego(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María Ángeles Gálvez-Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Paloma Moreno-Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Antonio C. Fuentes-Fayos(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), María Rosa Alhambra-Expósito(Instituto Maimónides de Investigación Biomédica de Córdoba), Cristóbal Blanco-Acevedo(Instituto Maimónides de Investigación Biomédica de Córdoba), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Elena de Dios(Instituto de Biomedicina de Sevilla), Juan Solivera(Instituto Maimónides de Investigación Biomédica de Córdoba), Ana Barrera-Martín(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 1
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251